Last Updated: Nov. 21, 2025 at 5:20 p.m. ET
First Published: Nov. 21, 2025 at 10:40 a.m. ET
Eli Lilly & Co. is the first pharmaceutical stock to hit a $1 trillion valuation, with its stock’s rise driven by a methodical approach to capturing an obesity-drug market that didn’t exist five years ago.
The Indianapolis drug giant’s stock LLY reached an intraday high of $1,061.17 in morning trading and closed at $1,059.70 on Friday, which was above the threshold of $1,057.78 needed for Lilly to become the 10th U.S. company with a $1 trillion market capitalization. It’s the only healthcare company to have made the cut to date.
